Jacobson Center for Clinical & Translational Research

Main Menu

/research/

Additional Information

 

Contact Us

Rheumatology Research

Study Title:  Pulmonary Arterial Hypertension (PAH) in scleroderma patents Quality Enhancement Research Initiative (QuERI) Extension Program. (Identifier: NCT01389206)

Study Purpose:  This program intends to improve the management of pulmonary arterial hypertension (PAH) patients through an evidence-based approach aimed at achieving optimal World Health Organization (WHO) functional class (FC): 1. Improving FC III & IV patients to FC II, 2. Improving FC II patients to FC I, and 3. Maintaining FC II & FC I patients.

Principal Investigator: Bashar Kahaleh, M.D.

Study Coordinator: Stephanie J. Smiddy, RN, for more information, please contact 419.383.6921.


Study Title:  A Pilot, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-220 in Subjects with Systemic Lupus Erythematosus (Identifier: NCT02185040)

Study Purpose:  The purpose of this study is to determine whether CC-220 is effective for the treatment of skin, joint and serological manifestations of systemic lupus erythematosus.

Principal Investigator: Bashar Kahaleh, M.D.

Study Coordinator: Stephanie J. Smiddy, RN, for more information, please contact 419.383.6921.

 

Last Updated: 1/30/15